The goal of this clinical trial is to compare the efficacy of Transversus Thoracic Muscle
Plane Block (TTMPB) integrated in a modern multi-modal analgesia protocol, following the
ERAS® recommendations, in adult patients undergoing planned cardiac surgery with sternotomy.
The main question it aims to answer is:
• Does addition of TTMPB to our analgesia protocol provides better postoperative pain relief
than standard of care alone ? This study will consist of two groups. The control group will
benefit of standard of care in the form of an institutional Intensive Care Unit-revisited
analgesia protocol. The intervention group will benefit of TTMP block with 40ml of
bupivacaine 0.375% (dose of 150 mg) and standard of care in the form of an institutional
Intensive Care Unit-revisited protocol.
Researchers will compare intervention group to control to see if patients from intervention
group obtain benefit in terms of opioid consumption, analgesia and early mobilization.